Probable systemic lupus erythematosus with cell-bound complement activation products (CB-CAPS)
Related Experiment Video
Updated: Mar 25, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
1Division of Rheumatology, MedStar Washington Hospital Center, Washington, DC, USA.
Abstract:
Complement activation is a key feature of systemic lupus erythematosus (SLE). Detection of cell-bound complement activation products (CB-CAPS) occurs more frequently than serum hypocomplementemia in definite lupus. We describe a patient with normocomplementemic probable SLE who did not fulfill ACR classification criteria for lupus, but the diagnosis was supported by the presence of CB-CAPS.
Related Concept Videos
Complement System
Hypersensitivity Reactions: Immune-Complex Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Drug Toxicity: Allergic Reactions

